Researchers at The Sciensano Institute in Belgium will be using urine collected through Colli-Pee ® to understand Chlamydia presence in all ages and genders in the Belgium population.
Novosanis has been co-awarded a CASUS grant, which allows to build a next-generation Colli-Pee ® that will be used in a molecular screening solution for cervical cancer.
Keeping #STDAwarenessMonth in mind, read our latest blog post highlighting research conducted by the Institute of Tropical Medicine in Antwerp, which shows great potential of home-based...
This website uses cookies to help us give you the best experience when you visit our website. By continuing to use this website, you consent to our use of these cookies.
Novosanis
